APPLICATION
NDA050788
TYPE
NDA
ORIGINAL APPROVAL
2002-12-04
LATEST ACTION
2025-07-10
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued
Products
CENTANYDiscontinued
MUPIROCIN 2% · OINTMENT · TOPICAL
Approval history
2014-09-15Manufacturing (CMC) · Supplement 4 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.